25I-NBOH
| 25I-NBOH | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
25I-NBOH is a synthetic psychedelic compound that belongs to the NBOH series of phenethylamines. It is a derivative of the 2C family of psychedelic phenethylamines, specifically related to 2C-I.
Chemical structure and properties
25I-NBOH is chemically known as 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-hydroxyphenyl)methyl]ethanamine. It features a phenethylamine core with a methoxy group at the 2 and 5 positions and an iodine atom at the 4 position of the phenyl ring. The NBOH series is characterized by the presence of a hydroxybenzyl group attached to the nitrogen atom.
Pharmacology
25I-NBOH acts as a potent agonist at the 5-HT2A receptor, which is the primary target for classical psychedelics. This receptor is a subtype of the serotonin receptor family and is involved in the modulation of mood, perception, and cognition. The activation of 5-HT2A receptors by 25I-NBOH is responsible for its psychedelic effects.
Effects
The effects of 25I-NBOH are similar to those of other psychedelics, such as LSD and psilocybin. Users report altered visual and auditory perceptions, changes in thought patterns, and an altered sense of time. The intensity and duration of these effects can vary depending on the dose and individual sensitivity.
Legal status
The legal status of 25I-NBOH varies by country. In some jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use. In others, it may be unscheduled but subject to analogue laws that regulate substances similar to controlled drugs.
Safety and toxicity
There is limited information on the safety and toxicity of 25I-NBOH. As with other research chemicals, the lack of comprehensive studies means that the long-term effects and potential risks are not well understood. Users should exercise caution and be aware of the potential for adverse reactions.
Related pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian